OCUL EBITDA
Ocular Therapeutix Inc · EBITDA
OCUL EBITDA
Latest reported-$74.12Mperiod ending
OCUL Quarterly EBITDA (-$2.96M → -$74.12M)
Quarterly EBITDA
High-resolution chart · PNG
OCUL ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -74,120,000 | |
| -84,552,000 | |
| -60,575,000 | |
| -65,347,000 | |
| -63,772,000 | |
| -60,088,000 | |
| -44,331,000 | |
| -32,310,000 | |
| -39,625,000 | |
| -59,877,000 | |
| -24,111,000 | |
| 3,800,000 | |
| -18,039,000 | |
| -28,067,000 | |
| -13,204,000 | |
| -21,882,000 | |
| -16,518,000 | |
| -10,302,000 | |
| -1,600,000 | |
| 4,909,000 | |
| -6,215,000 | |
| 5,446,000 | |
| -83,219,000 | |
| -9,564,000 | |
| -34,167,000 | |
| -19,145,000 | |
| -23,538,000 | |
| -16,458,000 | |
| -22,415,000 | |
| -15,330,000 | |
| -16,443,000 | |
| -14,013,000 | |
| -12,783,000 | |
| -12,714,000 | |
| -12,084,000 | |
| -14,594,000 | |
| -17,872,000 | |
| -15,319,000 | |
| -12,151,000 | |
| -8,954,000 | |
| -10,900,000 | |
| -10,304,000 | |
| -10,075,000 | |
| -10,980,000 | |
| -9,448,000 | |
| -6,940,000 | |
| -7,383,000 | |
| -6,776,000 | |
| -5,946,000 | |
| -6,872,000 | |
| -3,289,000 | |
| -3,336,000 | |
| -2,889,000 | |
| -2,958,000 |